FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 20, 2022 /PRNewswire/ Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer's
Net cash used in operating and investing activities was $35.5 million in the second quarter and $72.9 million for the first six months of 2022; quarter-end cash and restricted cash position was $510.1
The Food and Drug Administration has granted PRX012, an investigational anti-amyloid beta antibody therapy, Fast Track designation for the treatment of Alzheimer disease.